TrialThe AAPS journal2016

Establishing the Quantitative Relationship Between Lanreotide Autogel®, Chromogranin A, and Progression-Free Survival in Patients with Nonfunctioning Gastroenteropancreatic Neuroendocrine Tumors.

Núria Buil-Bruna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.